These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 23387202)
1. [Association of CD44 polymorphisms with genetic susceptibilities and clinico-pathologic characteristics in breast cancer]. Zhou X; Wu CY Sichuan Da Xue Xue Bao Yi Xue Ban; 2012 Nov; 43(6):807-11. PubMed ID: 23387202 [TBL] [Abstract][Full Text] [Related]
2. Association of p73 G4C14-A4T14 polymorphisms with genetic susceptibilities to breast cancer: a case-control study. Zhou X; Wu C Med Oncol; 2012 Dec; 29(5):3216-21. PubMed ID: 22535334 [TBL] [Abstract][Full Text] [Related]
3. Association of Single-Nucleotide Polymorphisms of CD44 Gene with Susceptibility to Breast Cancer in Chinese Women. Lin X; You X; Cao X; Pan S Med Sci Monit; 2018 May; 24():3077-3083. PubMed ID: 29748526 [TBL] [Abstract][Full Text] [Related]
4. [Association of single nucleotide polymorphisms in PAI-1 with breast cancer susceptibility and prognosis]. Chen YL; Jia YM; Xie YT; Li Y; Fang WG; Tian XX Zhonghua Bing Li Xue Za Zhi; 2016 Aug; 45(8):533-9. PubMed ID: 27510778 [TBL] [Abstract][Full Text] [Related]
5. Evaluation of the contribution of cyclooxygenase 2 genotypes to breast cancer in Taiwan. Su CH; Hsiao CL; Chang WS; Liu LC; Wang HC; Tsai CW; Li LY; Tsai CH; Bau DT Anticancer Res; 2014 Nov; 34(11):6711-6. PubMed ID: 25368279 [TBL] [Abstract][Full Text] [Related]
6. [Association between CD24 polymorphism and genetic susceptibility to breast cancer: a case-control study]. Zhou X; Cao Y; Luo J; Zeng X Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2013 Nov; 38(11):1122-9. PubMed ID: 24316932 [TBL] [Abstract][Full Text] [Related]
7. [Association of polymorphism in matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 with genetic susceptibility of gastric cancer]. Lin XD; Chen G; Li C; Zhang LY; Shi Y; Zhou DM; Zheng XW Zhonghua Yu Fang Yi Xue Za Zhi; 2011 Aug; 45(8):711-6. PubMed ID: 22169692 [TBL] [Abstract][Full Text] [Related]
8. Gene Combination of CD44 rs187116, CD133 rs2240688, NF-κB1 rs28362491 and GSTM1 Deletion as a Potential Biomarker in Risk Prediction of Breast Cancer in Lower Northern Thailand. Sapcharoen K; Sanguansermsri P; Yasothornsrikul S; Muisuk K; Srikummool M Asian Pac J Cancer Prev; 2019 Aug; 20(8):2493-2502. PubMed ID: 31450925 [TBL] [Abstract][Full Text] [Related]
9. Genetic Polymorphism in FSCN1 rs3801004 C/G and CD44 rs353639 A/C, as Prognostic Factor in Egyptian Breast Cancer Patients. Ibrahim NE; Raafat Hamed RM; Refaat A; Mosaad YO; Mekawy DM Asian Pac J Cancer Prev; 2023 Oct; 24(10):3517-3523. PubMed ID: 37898858 [TBL] [Abstract][Full Text] [Related]
10. LFA-1 gene polymorphisms are associated with the sporadic infiltrative duct breast carcinoma in Chinese Han women of Heilongjiang Province. Fu Z; Jiao M; Zhang M; Xu F; Yuan W; Pang D; Li D Breast Cancer Res Treat; 2011 May; 127(1):265-71. PubMed ID: 20953905 [TBL] [Abstract][Full Text] [Related]
11. TNRC9 rs12443621 and FGFR2 rs2981582 polymorphisms and breast cancer risk. Chen Y; Shi C; Guo Q World J Surg Oncol; 2016 Feb; 14(1):50. PubMed ID: 26911390 [TBL] [Abstract][Full Text] [Related]
12. CD44 gene polymorphisms and environmental factors on oral cancer susceptibility in Taiwan. Chou YE; Hsieh MJ; Hsin CH; Chiang WL; Lai YC; Lee YH; Huang SC; Yang SF; Lin CW PLoS One; 2014; 9(4):e93692. PubMed ID: 24699672 [TBL] [Abstract][Full Text] [Related]
13. CD44 rs13347 C>T polymorphism predicts breast cancer risk and prognosis in Chinese populations. Jiang L; Deng J; Zhu X; Zheng J; You Y; Li N; Wu H; Lu J; Zhou Y Breast Cancer Res; 2012 Jul; 14(4):R105. PubMed ID: 22788972 [TBL] [Abstract][Full Text] [Related]
14. Associations of polymorphisms in microRNAs with female breast cancer risk in Chinese population. He B; Pan Y; Xu Y; Deng Q; Sun H; Gao T; Wang S Tumour Biol; 2015 Jun; 36(6):4575-82. PubMed ID: 25613069 [TBL] [Abstract][Full Text] [Related]
15. ADRA2A Germline Gene Polymorphism is Associated to the Severity, but not to the Risk, of Breast Cancer. Kaabi B; Belaaloui G; Benbrahim W; Hamizi K; Sadelaoud M; Toumi W; Bounecer H Pathol Oncol Res; 2016 Apr; 22(2):357-65. PubMed ID: 26563278 [TBL] [Abstract][Full Text] [Related]
16. Impact of CD44 genetic variants on clinicopathological characteristics of uterine cervical cancer patients. Sun YH; Wang CM; Shen HP; Lee CY; Lin CW; Yang SF; Wang PH Int J Med Sci; 2024; 21(8):1428-1437. PubMed ID: 38903932 [TBL] [Abstract][Full Text] [Related]
17. CD44 gene polymorphisms in breast cancer risk and prognosis: a study in North Indian population. Tulsyan S; Agarwal G; Lal P; Agrawal S; Mittal RD; Mittal B PLoS One; 2013; 8(8):e71073. PubMed ID: 23940692 [TBL] [Abstract][Full Text] [Related]
18. [Association of murine double minute 2 and P53 polymorphisms with breast cancer susceptibility]. Wang ML; Xu YX; Qian J; Wang FH Zhonghua Yu Fang Yi Xue Za Zhi; 2013 Feb; 47(2):124-8. PubMed ID: 23719102 [TBL] [Abstract][Full Text] [Related]
19. CD24 polymorphisms cannot predict pathologic complete response to anthracycline- and taxane-based neoadjuvant chemotherapy in breast cancer. Zhou X Clin Breast Cancer; 2014 Apr; 14(2):e33-40. PubMed ID: 24393851 [TBL] [Abstract][Full Text] [Related]
20. Significant association between ERCC2 and MTHR polymorphisms and breast cancer susceptibility in Moroccan population: genotype and haplotype analysis in a case-control study. Hardi H; Melki R; Boughaleb Z; El Harroudi T; Aissaoui S; Boukhatem N BMC Cancer; 2018 Mar; 18(1):292. PubMed ID: 29544444 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]